Clinical Trials

NCT06337318 | RECRUITING | PHASE3

600 participants

Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2024-10-23

Completion:

2032-03-31

Conditions

• Classic Follicular Lymphoma
• Follicular Lymphoma With Unusual Cytological Features

Interventions

• PROCEDURE
• BIOLOGICAL

No Results Yet

NCT06337084 | ACTIVE_NOT_RECRUITING | PHASE1

12 participants

Diagnostic Efficacy and Dosimetry of MNPR-101-DFO*-89Zr in Patients With Solid Tumors

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2024-05-30

Completion:

2026-12-31

Conditions

• Solid Tumor, Adult
• Bladder Cancer
• Urothelial Carcinoma
• Triple-negative Breast Cancer
• Lung Cancer
• Colorectal Cancer
• Gastric Cancer
• Ovarian Cancer
• Pancreatic Cancer

Interventions

• DRUG
• DIAGNOSTIC_TEST

No Results Yet

NCT06327373 | WITHDRAWN | PHASE1/PHASE2

0 participants

A Feasibility Study of Supplemental Oxygen to Improve Pulmonary Hypertension in People With Intradialytic Hypoxemia

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2026-07-01

Completion:

2027-06-30

Conditions

• Pulmonary Hypertension

Interventions

• DRUG

No Results Yet

NCT06322264 | RECRUITING

220 participants

Promoting Children's Participation in Conventional X-ray Examinations

Study Type:

OBSERVATIONAL

Last Updated:

2026-09-03

Start Date:

2024-11-05

Completion:

2027-12-31

Conditions

• Heart Rate Determination
• Patient Participation

Interventions

• DIAGNOSTIC_TEST

No Results Yet

NCT06318169 | RECRUITING | PHASE3

1350 participants

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2024-03-13

Completion:

2029-02-28

Conditions

• Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis

Interventions

• BIOLOGICAL
• OTHER

No Results Yet

NCT06312332 | COMPLETED | NA

14 participants

Michigan Emergency Department Improvement Collaborative (MEDIC) Alert; Pulmonary Embolism (PE)

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2024-03-01

Completion:

2026-08-31

Conditions

• Pulmonary Embolism

Interventions

• BEHAVIORAL

No Results Yet

NCT06312176 | RECRUITING | PHASE3

1200 participants

A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2024-04-14

Completion:

2027-07-11

Conditions

• Breast Neoplasms

Interventions

• DRUG
• BIOLOGICAL

No Results Yet

NCT06300138 | RECRUITING | NA

150 participants

Antifungal Agents and Infrared Thermotherapy Alone or in Combination in the Treatment of Sporotrichosis

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2024-03-15

Completion:

2026-12-31

Conditions

• Sporotrichosis

Interventions

• DRUG
• DEVICE
• OTHER

No Results Yet

NCT06278961 | ACTIVE_NOT_RECRUITING

350 participants

Families Filming Infants Learning Movement

Study Type:

OBSERVATIONAL

Last Updated:

2026-09-03

Start Date:

2021-01-28

Completion:

2026-09-30

Conditions

• Infant Development
• Cerebral Palsy
• Motor Disorders
• Neurological Disorder

Interventions

• OTHER

No Results Yet

NCT06272968 | ACTIVE_NOT_RECRUITING

30 participants

Predicting Cognition After DBS for Parkinson's Disease 2

Study Type:

OBSERVATIONAL

Last Updated:

2026-09-03

Start Date:

2024-10-01

Completion:

2027-12-01

Conditions

• Cognitive Impairment

Interventions

• DIAGNOSTIC_TEST

No Results Yet

NCT06271837 | ACTIVE_NOT_RECRUITING | PHASE2

127 participants

A Study of T-DXd as Monotherapy or in Combination With Anti-cancer Agents in Patients With Selected HER2-expressing Tumors

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2024-02-22

Completion:

2027-02-10

Conditions

• Advanced Solid Tumors (Excluding Gastric Cancer and Breast Cancer)

Interventions

• DRUG

No Results Yet

NCT06271291 | RECRUITING

30000 participants

Pancreatic Cancer Detection Consortium (PCDC) Prospective Cohorts

Study Type:

OBSERVATIONAL

Last Updated:

2026-09-03

Start Date:

2024-12-12

Completion:

2029-11-01

Conditions

• Pancreatic Carcinoma

Interventions

• OTHER

No Results Yet

NCT06269627 | RECRUITING | PHASE4

48 participants

Temporally-Resolved Electrophysiology of Acamprosate Treatment of Alcohol Use Disorder

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2025-05-07

Completion:

2026-12-31

Conditions

• Alcohol Use Disorder

Interventions

• DRUG
• OTHER

No Results Yet

NCT06267859 | ENROLLING_BY_INVITATION | EARLY_PHASE1

600 participants

Development of Methods for Effective Treatment and Improvement of Common Somatic Diseases in Children

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2023-11-08

Completion:

2032-01-30

Conditions

• Respiratory Diseases
• Congenital Heart Defects

Interventions

• COMBINATION_PRODUCT

No Results Yet

NCT06252649 | RECRUITING | PHASE3

450 participants

Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2024-07-17

Completion:

2028-09-25

Conditions

• Metastatic Colorectal Cancer

Interventions

• DRUG

No Results Yet

NCT06245889 | RECRUITING | PHASE2

30 participants

PET Dynamics to Response-Adapted Neoadjuvant Therapy in TNBC

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2024-05-01

Completion:

2029-06-30

Conditions

• Triple Negative Breast Cancer

Interventions

• DRUG

No Results Yet

NCT06234995 | RECRUITING | PHASE4

80 participants

Cortical Electrophysiology of Response Inhibition in Parkinson's Disease

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2021-08-09

Completion:

2027-09-30

Conditions

• Parkinson Disease

Interventions

• DRUG
• DEVICE

No Results Yet

NCT06232044 | SUSPENDED | PHASE1/PHASE2

88 participants

Testing the Combination of Two Approved Drugs and One Experimental Drug in Patients With Relapsed or Refractory Multiple Myeloma

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2025-04-23

Completion:

2028-05-01

Conditions

• Recurrent Multiple Myeloma
• Refractory Multiple Myeloma

Interventions

• DRUG
• BIOLOGICAL
• PROCEDURE

No Results Yet

NCT06229418 | RECRUITING | NA

128 participants

Developing and Testing Drone-Delivered AEDs for Cardiac Arrests In Rural America

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2025-09-08

Completion:

2027-03-31

Conditions

• Cardiac Arrest
• Sudden Cardiac Arrest

Interventions

• OTHER

No Results Yet

NCT06228937 | RECRUITING

60 participants

Gut Microbiota in Patients With Limb Lymphedema and Recurrent Lymphangitis

Study Type:

OBSERVATIONAL

Last Updated:

2026-09-03

Start Date:

2024-02-22

Completion:

2027-10-30

Conditions

• Lymphedema
• Microbiota

Interventions

• OTHER

No Results Yet

NCT06227611 | RECRUITING

16 participants

Evaluation of Different Perimetric Grids to Detect Central Visual Field Defect in Glaucoma Patients With Reduce Ganglion Cell Layer Thickness Measured by Spectral Domain OCT.

Study Type:

OBSERVATIONAL

Last Updated:

2026-09-03

Start Date:

2021-05-04

Completion:

2022-05-04

Conditions

• Glaucoma

No Results Yet

NCT06221787 | COMPLETED | NA

80 participants

Stem Cell Derived Exosomes in the Treatment of Melasma and Its Percutaneous Penetration

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2022-04-01

Completion:

2025-08-01

Conditions

• Melasma

Interventions

• PROCEDURE

No Results Yet

NCT06206252 | COMPLETED

110 participants

Can Medical Cannabis Affect Opioid Use?

Study Type:

OBSERVATIONAL

Last Updated:

2026-09-03

Start Date:

2023-09-07

Completion:

2025-12-02

Conditions

• Chronic Pain
• Pain

Interventions

• OTHER

No Results Yet

NCT06206135 | RECRUITING

172 participants

Multicenter, Open, Prospective, 48 Weeks, Observational Study ,Evaluate the Safety and Efficacy of Nephoxil Capsule

Study Type:

OBSERVATIONAL

Last Updated:

2026-09-03

Start Date:

2023-12-21

Completion:

2028-02-28

Conditions

• Hyperphosphatemia

Interventions

• DRUG

No Results Yet

NCT06205628 | ACTIVE_NOT_RECRUITING | PHASE1

28 participants

Safety, Tolerability, PK and PD of ADX-850 in Participants With Hypertension

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2024-03-21

Completion:

2026-07-31

Conditions

• Hypertension
• Hypertension,Essential

Interventions

• DRUG

No Results Yet

NCT06195982 | COMPLETED | PHASE2

25 participants

Ketones in Heart Failure With Reduced Ejection Fraction

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2024-03-06

Completion:

2026-08-27

Conditions

• Heart Failure With Reduced Ejection Fraction

Interventions

• DIETARY_SUPPLEMENT

No Results Yet

NCT06177639 | COMPLETED

18 participants

Widefield Confocal Scanning Laser Ophthalmoscope Optimized for Pediatric and Neonatal Imaging

Study Type:

OBSERVATIONAL

Last Updated:

2026-09-03

Start Date:

2025-10-01

Completion:

2026-04-22

Conditions

• Eye Diseases

Interventions

• DEVICE

No Results Yet

NCT06171256 | WITHHELD

[Trial of device that is not approved or cleared by the U.S. FDA]

Last Updated:

2026-09-03

No Results Yet

NCT06170788 | RECRUITING | PHASE3

614 participants

Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2023-12-15

Completion:

2028-01-25

Conditions

• Non-small Cell Lung Cancer (NSCLC)

Interventions

• BIOLOGICAL
• DRUG

No Results Yet

NCT06170216 | COMPLETED

206 participants

Different Immunochemotherapies in Small B-cell Non-Hodgkin Lymphoma (iNHL)

Study Type:

OBSERVATIONAL

Last Updated:

2026-09-03

Start Date:

2023-01-10

Completion:

2023-12-19

Conditions

• Lymphoma, Non-Hodgkin

Interventions

• DRUG

No Results Yet

NCT06163534 | RECRUITING

500 participants

A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)

Study Type:

OBSERVATIONAL

Last Updated:

2026-09-03

Start Date:

2024-08-01

Completion:

2028-03-01

Conditions

• Head and Neck Squamous Cell Carcinoma

No Results Yet

NCT06156410 | RECRUITING | PHASE1

30 participants

Cabozantinib With Ifosfamide in Relapsed/Refractory Sarcomas

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2023-10-24

Completion:

2027-11-30

Conditions

• Ewing Sarcoma
• Osteosarcoma
• Sarcomas

Interventions

• DRUG

No Results Yet

NCT06143293 | ACTIVE_NOT_RECRUITING | NA

144 participants

RESEARCH EVALUATING VAGAL EXCITATION AND ANATOMICAL LINKS

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2023-12-15

Completion:

2027-08-31

Conditions

• Epilepsy
• Depressive Disorder

Interventions

• DEVICE

No Results Yet

NCT06138067 | RECRUITING | NA

90 participants

Patient Navigation Program to Improve Clinical Trial Enrollment in Cancer Patients

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2025-12-01

Completion:

2027-09-30

Conditions

• Prostate Cancer
• Kidney Cancer

Interventions

• BEHAVIORAL

No Results Yet

NCT06137261 | ACTIVE_NOT_RECRUITING | NA

420 participants

Screening Adults With Obesity to Reduce Heart Failure Events

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2024-02-26

Completion:

2026-12-08

Conditions

• Obesity
• Heart Failure

Interventions

• DIAGNOSTIC_TEST

No Results Yet

NCT06136624 | RECRUITING | PHASE3

1310 participants

Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2023-12-31

Completion:

2028-08-02

Conditions

• Prostate Cancer Metastatic

Interventions

• DRUG

No Results Yet

NCT06129864 | RECRUITING | PHASE3

1145 participants

A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2023-12-14

Completion:

2030-04-17

Conditions

• Locally Advanced Head and Neck Squamous Cell Carcinoma

Interventions

• DRUG

No Results Yet

NCT06128447 | RECRUITING | PHASE3

300 participants

Phase 3, Multi-center, Prospective, Randomized, Double-blind, Placebo- Controlled Study to Evaluate the Effectiveness and Safety of ZP5-9676 for the Treatment of Soil Transmitted Helminthiasis (STH)

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2025-02-14

Completion:

2027-03-01

Conditions

• Soil-Transmitted Helminthiasis (STH)

Interventions

• DRUG

No Results Yet

NCT06125847 | RECRUITING | EARLY_PHASE1

21 participants

NGGT006 Gene Therapy for Homozygous Familial Hypercholesterolemia

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2023-10-29

Completion:

2027-03-30

Conditions

• Homozygous Familial Hypercholesterolemia

Interventions

• GENETIC

No Results Yet

NCT06115265 | RECRUITING | NA

40 participants

Ketogenic Diet and Diabetes Demonstration Project

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2023-09-05

Completion:

2026-10-30

Conditions

• Type 2 Diabetes
• PreDiabetes
• Obesity
• Ketogenic Dieting

Interventions

• BEHAVIORAL

No Results Yet